HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Toronto Dominion Bank

Toronto Dominion Bank lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.4% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 114,189 shares of the company’s stock after buying an additional 1,593 shares during the period. Toronto Dominion Bank’s holdings in HCA Healthcare were worth $38,085,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after purchasing an additional 60,304 shares during the period. Sanders Capital LLC increased its stake in shares of HCA Healthcare by 4.2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after acquiring an additional 456,738 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of HCA Healthcare by 1.7% in the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after acquiring an additional 170,560 shares during the last quarter. Royal Bank of Canada raised its stake in HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock worth $1,219,121,000 after purchasing an additional 1,183,890 shares during the period. Finally, Norges Bank purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $694,985,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages recently weighed in on HCA. Robert W. Baird started coverage on HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price on the stock. JPMorgan Chase & Co. increased their price objective on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a research report on Thursday, May 30th. Barclays lifted their target price on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday. Cantor Fitzgerald restated an “overweight” rating and set a $335.00 price objective on shares of HCA Healthcare in a research note on Wednesday. Finally, Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Four investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $339.72.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the transaction, the executive vice president now directly owns 34,124 shares in the company, valued at $10,544,316. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,863 shares of the business’s stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total value of $607,673.34. Following the sale, the senior vice president now directly owns 19,612 shares in the company, valued at $6,397,042.16. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the transaction, the executive vice president now directly owns 34,124 shares in the company, valued at approximately $10,544,316. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock worth $3,921,929 in the last 90 days. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock traded up $1.99 on Friday, reaching $354.78. 1,215,921 shares of the company were exchanged, compared to its average volume of 1,159,920. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $356.30. The firm has a market cap of $92.92 billion, a price-to-earnings ratio of 17.69, a P/E/G ratio of 1.38 and a beta of 1.68. The company has a debt-to-equity ratio of 27.11, a quick ratio of 1.02 and a current ratio of 1.06. The company’s 50-day moving average is $330.12 and its two-hundred day moving average is $323.02.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The business had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter last year, the company earned $4.29 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 22.38 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.